上诉人（原审原告）：江陵县享发实业有限公司，法定代表人黄振华；委托 诉讼代理人陈琴、陈兵，湖北荆安律师事务所律师。 证券代码：300391 证券简称：*ST长药 公告编号：2025-060 长江医药控股股份有限公司 重大诉讼进展的公告 本公司及董事会全体成员保证信息披露内容真实、准确和完整，没有虚假记载、误导性 陈述或重大遗漏。 重要内容提示： 原告江陵县享发实业有限公司与被告长江医药控股股份有限公司、第三人湖 北安博制药有限公司股权转让纠纷案，湖北省江陵县人民法院一审判决后，江陵 县享发实业有限公司与长药控股提起上诉。2025年5月22日，湖北省荆州市中级 人民法院裁定准许长药控股撤回上诉，江陵县享发实业有限公司上诉部分按自动 撤回上诉处理。本案涉案金额8,315万元，涉及的1482.05万元预计将对公司当期 损益产生影响。 一、诉讼、仲裁事项的基本情况 长江医药控股股份有限公司（以下简称"公司"、"长药控股"）于2025年 5月23日收到湖北省荆州市中级人民法院出具的民事裁定书。湖北省荆州市中级 人民法院所在地为湖北省荆州市荆州区学苑路9号。诉讼各方当事人如下： 上诉人（原审被告）：长江医药控股股份有限公 ...

证券代码：300391 证券简称：*ST长药 编号：2025-059 长江医药控股股份有限公司 2025年第二次临时股东会决议公告 本公司及董事会全体成员保证信息披露内容真实、准确和完整，不存在虚假记载、误 导性陈述或者重大遗漏。 特别提示： 1、本次股东会无增加、变更、否决提案的情况； 2、本次股东会以现场投票表决和网络投票表决的方式召开。 （2）网络投票时间：2025 年 5 月 23 日。其中，通过深圳证券交易所交易 系统进行网络投票的时间为 2025 年 5 月 23 日上午 9:15-9:25，9:30-11:30， 下午 13:00-15:00；通过深圳证券交易所互联网系统投票的具体时间为 2025 年 5 月 23 日 9:15-15:00。 4、股权登记日：2025 年 5 月 16 日（星期五） 一、会议召开和出席情况 1、召集人：公司董事会 5、现场会议召开地点：公司会议室（十堰市郧阳经济开发区天马大道特 69 号） 2、召开方式：现场投票与网络投票相结合的方式 3、召开时间： （1）现场会议时间：2025 年 5 月 23 日（星期五）下午 15:30 6、会议主持人：公司董事长王波先生 ...

关于长江医药控股股份有限公司 2025 年第二次临时股东大会的 湖北英达律师事务所 法律意见书 中国武汉市新华路 186 号福星国际商会大厦 18 楼 电话：86.27.85350032 传真：86.27.85350997 邮政编码：430022 网址:www.yingdalaw.com 二〇二五年五月 英达律师事务所 法律意见书 湖北英达律师事务所 关于长江医药控股股份有限公司 2025 年第二次临时股东大会的 法律意见书 致：长江医药控股股份有限公司 湖北英达律师事务所（下称"本所"）接受长江医药控股股份有限公司（下称 "公司"）委托，指派本所律师宋浩、周凌雷现场见证公司于 2025 年 5 月 23 日召 开的 2025 年第二次临时股东大会（以下简称"本次股东大会"），并根据《中华 人民共和国公司法》（下称"《公司法》"）、《中华人民共和国证券法》（下称 "《证券法》"）、中国证券监督管理委员会发布的《上市公司股东大会规则》（下 称"《股东大会规则》"）等相关法律、法规、规范性文件以及《长江医药控股股 份有限公司章程》（下称"《公司章程》"）的有关规定，就本次股东大会的召集 和召开程序、出席会议人员的 ...

Group 1 - BYD reported August sales of 174,915 new energy vehicles, a year-on-year increase of 184.84% [1] - Cumulative sales from January to August reached 978,795 units, representing a year-on-year growth of 267.31% [1] - The company sold 5,092 new energy passenger vehicles overseas in August [1] Group 2 - Zhongke Electric's subsidiary plans to establish a joint venture with Chongqing Fudi for the production of anode materials, with a registered capital of 1 billion RMB [2] - Zhongke Electric's subsidiary will contribute 650 million RMB, while Chongqing Fudi will contribute 350 million RMB [2] Group 3 - Yuyuan Group intends to transfer 13% of its shares in Jinhuijiu for approximately 1.937 billion RMB, reducing its stake to 25% [3] - The company plans to further reduce its holdings by more than 5% within the next six months [3] Group 4 - Lizhu Group's recombinant COVID-19 fusion protein vaccine has been included in the emergency use for sequential booster immunization [4] Group 5 - Guanghui Energy plans to repurchase shares worth between 800 million and 1 billion RMB to support employee stock ownership plans [5] Group 6 - Cambrian has launched four cloud-based intelligent chips, although mass sales will require a longer time frame and initial technical service investments [7] Group 7 - LePu Medical has received approval from the China Securities Regulatory Commission for the issuance of Global Depositary Receipts (GDRs) and listing on the Swiss Stock Exchange [9] - The GDR issuance will correspond to no more than 180,458,875 new A-shares [9] Group 8 - Fushi Holdings' subsidiary has entered into an exclusive advertising agency cooperation with the Central Radio and Television Station's automotive channel for three years [10] Group 9 - Guangzhou Port's container throughput in August was 1.981 million TEUs, a year-on-year increase of 2.4% [11] - The total cargo throughput for August was 44.788 million tons, a decrease of 0.6% [11] Group 10 - Ningbo Port expects to complete a container throughput of 3.58 million TEUs in August, a year-on-year increase of 10.2% [12] - The total cargo throughput is projected to decline by 3.0% [12] Group 11 - Ming Tai Aluminum reported a 7% year-on-year decrease in aluminum plate and strip sales in August, while aluminum profile sales increased by 47% [13] Group 12 - Electric Power Investment plans to invest in multiple wind and solar projects, with total static investments of 1.585 billion RMB for wind and 538 million RMB for solar [14] Group 13 - Northeast Pharmaceutical has signed a cooperation agreement with MedAbome for the development of the MAb11-22.1 antibody project [19] Group 14 - New Five Feng plans to acquire equity in Tianxin Seed Industry and several other companies for a total price of approximately 2.208 billion RMB [26] Group 15 - Sumeida's subsidiary plans to transfer 100% equity of eight photovoltaic power station project companies, with an estimated transaction value of 657 million RMB [27] Group 16 - *ST Tongzhou intends to acquire 51% equity in Tongtaiwei, fulfilling the capital contribution obligation of 10.2 million RMB [29] Group 17 - Tianyin Holdings' subsidiary plans to invest 120 million RMB in Xundong Xintong to acquire 40% equity [30] Group 18 - Hainan Haiyao plans to publicly transfer 43% equity in Shanghai Lishengte to attract new investors [31] Group 19 - New Asia Process plans to transfer 7.76% of its shares to Xiangcai New Materials at a price of 5.274 RMB per share [32] Group 20 - Lanwei Medical plans to raise no more than 664 million RMB through a private placement for provincial laboratory construction projects [34] Group 21 - Lida New Materials plans to issue convertible bonds to raise no more than 300 million RMB for a new aluminum material project [35] Group 22 - Gekewei has successfully launched its 12-inch CIS integrated circuit project, achieving over 95% yield [51] Group 23 - Baijin Medical's tricuspid valve ring product has received registration approval [52] Group 24 - Shanghai Pharmaceuticals has received approval to initiate Phase I clinical trials for a recombinant anti-CD20 humanized monoclonal antibody [53] Group 25 - Junda Co. has increased the production capacity of its solar cell production base project from 8GW to 10GW [54]

2025年5月12日，长江医药控股股份有限公司（以下简称"公司"、"长药 控股"）收到湖北省武汉市中级人民法院执行裁定书。湖北省武汉市中级人民法 院所在地为湖北省武汉市江汉区常青路156号。诉讼各方当事人如下： 申请执行人：武汉农村商业银行股份有限公司武昌支行，负责人万国庆。 被执行人：湖北长江星医药股份有限公司，法定代表人罗飞；湖北长江丰医 药有限公司，法定代表人贺元峰；湖北长江源制药有限公司，法定代表人罗飞； 石首市国际大酒店有限公司，法定代表人张芳芳；湖北长江大药房连锁有限公司， 法定代表人阳勇；湖北舒惠涛药业有限公司，法定代表人胡士会；湖北长江大药 房连锁武汉有限公司，法定代表人张兰；长江医药控股股份有限公司，法定代表 人胡士会；罗明、张莉、田良辉。 二、有关案件的基本情况 原告武汉农村商业银行股份有限公司武昌支行与被告湖北长江星医药股份 有限公司、湖北长江丰医药有限公司、湖北长江源制药有限公司、石首市国际大 酒店有限公司、湖北长江大药房连锁有限公司、湖北舒惠涛药业有限公司、湖北 长江大药房连锁武汉有限公司、长江医药控股股份有限公司、罗明、张莉、田良 辉金融借款合同纠纷案的基本情况，详见公司于2023 ...

证券代码：300391 证券简称：*ST长药 编号：2025-057 长江医药控股股份有限公司 2024年度股东会决议公告 1、本次股东会无增加、变更、否决提案的情况； 本公司及董事会全体成员保证信息披露内容真实、准确和完整，不存在虚假记载、误 导性陈述或者重大遗漏。 特别提示： 2、本次股东会以现场投票表决和网络投票表决的方式召开。 一、会议召开和出席情况 1、召集人：公司董事会 2、召开方式：现场投票与网络投票相结合的方式 3、召开时间： （1）现场会议时间：2025 年 5 月 13 日（星期二）下午 15:30 6、会议主持人：公司董事长王波先生。 7、会议出席情况： （1）出席会议的总体情况 参加会议的股东（代理人）共 91 名，所持（代理）股份 38,821,200 股，占 1 （2）网络投票时间：2025 年 5 月 13 日。其中，通过深圳证券交易所交易 系统进行网络投票的时间为 2025 年 5 月 13 日上午 9:15-9:25，9:30-11:30， 下午 13:00-15:00；通过深圳证券交易所互联网系统投票的具体时间为 2025 年 5 月 13 日 9:15-15:00。 4、 ...

湖北英达律师事务所 关于长江医药控股股份有限公司 2024 年年度股东大会的 法律意见书 中国武汉市新华路 186 号福星国际商会大厦 18 楼 电话：86.27.85350032 传真：86.27.85350997 邮政编码：430022 网址:www.yingdalaw.com 二○二五年五月 英达律师事务所 法律意见书 湖北英达律师事务所 关于长江医药控股股份有限公司 2024 年年度股东大会的 法律意见书 致：长江医药控股股份有限公司 湖北英达律师事务所（下称"本所"）接受长江医药控股股份有限公司（下称 "公司"）委托，指派本所律师宋浩、周凌雷现场见证公司于 2025 年 5 月 13 日 召开的 2024 年年度股东大会（以下简称"本次股东大会"），并根据《中华人民 共和国公司法》（下称"《公司法》"）、《中华人民共和国证券法》（下称"《证 券法》"）、中国证券监督管理委员会发布的《上市公司股东大会规则》（下称 "《股东大会规则》"）等相关法律、法规、规范性文件以及《长江医药控股股份 有限公司章程》（下称"《公司章程》"）的有关规定，就本次股东大会的召集和 召开程序、出席会议人员的资格和召集人资格、 ...

Group 1: New Stock Offerings - ST Xinchao (600777) has a tender offer period from April 23, 2025, to May 22, 2025[1] - Puli Tui (300630) has 7 trading days remaining until the last trading day[1] - ST Zhongcheng (300208) reported severe abnormal fluctuations[1] Group 2: Trading Alerts - Jintai (300225) and other stocks are under observation for trading alerts due to abnormal fluctuations[1] - ST Yida (600608) and ST Huke (600608) are also flagged for trading alerts[1] - Multiple stocks including ST Shengda (002259) and ST Yushun (002289) are under scrutiny for trading activities[1] Group 3: Recent Announcements - Guofang Group (601086) and other companies have made recent announcements regarding their stock activities[1] - A total of 7 trading days remain for several stocks approaching their last trading day[1] - Various companies including ST Huada (603580) and ST Aiai (603580) have made recent disclosures[1]

Group 1: Company Restructuring and Financial Status - The company signed a restructuring investment agreement on May 6, 2025, and the pre-restructuring work is progressing in an orderly manner [1] - The audited net assets attributable to the parent company for 2024 are negative, posing a risk of stock delisting [2] - If the restructuring is successful, it will significantly improve the company's financial status and reduce debt [3] Group 2: Stock Increase and Capital Structure - The company plans to increase its capital by converting 10 shares into 15 shares, resulting in a total share capital increase from 350,336,112 shares to 875,840,280 shares [2] - The conversion price is set at 2.42 CNY per share, with a total of 525,504,168 shares available for conversion [2] - Remaining shares after the restructuring will be used to repay ordinary creditors at a price not lower than 10 CNY per share [2] Group 3: Investor Relations and Market Concerns - The company is addressing investor concerns regarding stock price fluctuations influenced by various factors, including company performance and market conditions [2] - There is no current request from industry investors to change the company's main business [2] - The company has not received any consent letters from the China Securities Regulatory Commission regarding the restructuring [3] Group 4: Management and Operational Changes - If the restructuring is successful, the controlling shareholder will change to Sichuan Jiadaobowen Ecological Technology Co., Ltd. [3] - The new industry investors are expected to recommend talent to enhance the company's operational capabilities [4] - The company currently has no specific plans for its photovoltaic sector [3]

Core Points - The Shanghai Composite Index is at 3343.28 points, slightly down by 0.26%, with a total trading volume of 590.62 billion yuan [1] - 24 A-shares have surpassed their annual moving average, with notable stocks showing significant deviation rates [1] Summary by Category Stock Performance - Huaihe Energy (600575) has the highest deviation rate at 9.45%, with a daily increase of 10.03% and a turnover rate of 4.61% [2] - *ST Changyao (300391) follows with a deviation rate of 3.71%, increasing by 4.37% today [2] - Shuiyang Co., Ltd. (300740) shows a deviation rate of 3.58% with an 8.70% increase [2] Other Notable Stocks - *ST Chuangxing (600193) has a deviation rate of 3.47% and a daily increase of 4.94% [2] - Yahua Electronics (301337) has a deviation rate of 3.40% with a 5.06% increase [2] - Shaanxi Huada (301517) shows a 4.25% increase and a deviation rate of 3.38% [2] Market Overview - The overall A-share market is experiencing fluctuations, with a total trading volume of 590.62 billion yuan, indicating active trading [1]